Pyrogallol acts as a novel anticancer factor to enhance the sensitivity to cisplatin in ovarian cancer cells through inducing miR-15a upregulation
Abstract Introduction Pyrogallol is a catechin compound, as an active ingredient extracted from Emblica officinalis, has antiproliferative and antiapoptotic effects on some of the human cancer cells. Cisplatin is known as an effective chemotherapeutic agent against cancer by inducing DNA damage and...
Saved in:
Main Authors: | Azin Shirani, Razieh Mirabbasi, Leila Shabani, Somayeh Reiisi |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2025-01-01
|
Series: | Egyptian Journal of Medical Human Genetics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43042-025-00647-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells
by: Stefano Miglietta, et al.
Published: (2025-01-01) -
Tumor-associated macrophage-derived exosome miR-194 confers cisplatin resistance in GC cells
by: Yi Zhou, et al.
Published: (2025-02-01) -
Protective effects of Pyrogallol and Caffeic acid against Fe2+ -Ascorbate-induced oxidative stress in the wistar rats liver: An in vitro study
by: Seifollah Bahramikia, et al.
Published: (2025-02-01) -
Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer
by: Taha Umair Wani, et al.
Published: (2025-01-01) -
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion
by: Lydia C. Powell, et al.
Published: (2025-02-01)